NNOX Nano-X Imaging Ltd.

NNOX financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1795251 Exchange: Nasdaq SIC: 3844 (X-Ray Apparatus & Tubes & Related Irradiation Apparatus) Latest filing: 20-F filed Apr 30, 2026 Data checked: Oct 21, 2026
Showing 3 of 8 annual and 0 of 0 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Accelerated filer
Entity Type
Other
Industry (SIC)
3844 X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Incorporated
L3
Fiscal Year End
December (1231)
Phone
972-37359202
EIN
000000000
Headquarters
PETACH TIKVA, L3, 4970602

▼ Key Metrics (FY 2025)

As of Dec 31, 2025
Financials
Revenue
$13.02M
Net Income
$-75.02M
Total Assets
$162.17M
Total Equity
$139.73M
Total Debt
-
Free Cash Flow
$-45.00M
Ratios
Gross Margin
-98.2%
Operating Margin
-600.8%
Net Margin
-576.1%
Return on Equity
-53.7%
Return on Assets
-46.3%
Current Ratio
3.96x
FCF / Assets
-27.7%
Revenue Growth (YoY)
15.4%
EPS Growth (YoY)
-27.5%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Nano-X Imaging Ltd. generated $13.02M of revenue in fiscal 2025, with net loss of $75.02M and an operating cash outflow of $40.79M. The $13.02M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Revenue was 15.4% above fiscal 2024 revenue of $11.28M, marking a year-over-year increase. Diluted earnings per share were -$1.16, translating the period’s attributable earnings into the amount reported for each diluted share. Diluted shares averaged 64.79K; this is the reported share base over which the company’s diluted per-share earnings were spread. Total assets stood at $162.16M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. The revenue-to-assets relationship was 0.08x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

Direct costs exceeded revenue, producing a gross loss of $12.79M before operating expenses. The gross loss equaled 98.2% of revenue, quantifying the direct-cost deficit before operating expenses. Operations produced a $78.23M operating loss before non-operating and tax effects. Relative to revenue, the operating deficit measured 600.8%, showing the shortfall after operating costs. The company ended the period with a net loss of $75.02M, extending the operating result through all remaining items. The net loss equaled 576.1% of revenue, showing the bottom-line deficit relative to the company’s sales base. EBITDA was negative $77.05M, showing a deficit before interest, taxes, depreciation, and amortization. The pretax result was a loss of $76.81M, establishing the deficit before tax effects. Pretax margin was -589.9%, reflecting a pre-tax loss equal to 589.9% of revenue. The company recognized an income-tax benefit of $1.79M, increasing after-tax earnings relative to the pretax result. Relative to period-end equity, the net loss represented 53.7%. The net loss equaled 46.3% of period-end assets, showing the deficit relative to the asset base. The bottom-line deficit increased from $53.52M in fiscal 2024 to $75.02M.

Liquidity and Capital Structure

The company held $162.16M of assets against $22.43M of liabilities and $139.73M of equity, revealing how the asset base was financed. Current assets were $66.79M against $16.89M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. Current assets covered current liabilities by 3.96x, leaving a positive buffer for near-term obligations. Cash and equivalents totaled $49.15M, identifying the most liquid reported component available within the broader current-asset balance. Cash and equivalents represented 291.0% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. The equity-to-assets relationship was 86.2%, placing book capital against the total resource base. The liabilities-to-assets relationship was 13.8%, placing reported obligations against the full positive asset balance. The cash-to-assets relationship was 30.3%, comparing reported cash and equivalents with the full positive asset balance. Total assets were 22.8% lower than fiscal 2024 assets of $210.00M, measuring the company’s own balance-sheet change. Book equity was 26.1% lower than fiscal 2024 equity of $189.12M, showing how shareholder capital changed year over year. Cash and equivalents were 25.1% higher than fiscal 2024 cash of $39.30M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Cash flow from operations was an outflow of $40.79M, showing that operations absorbed cash during the period. Capital expenditures used $4.21M in addition to the operating cash outflow, increasing the total cash consumed by operations and investment during the period. Operating cash flow and capital spending combined to leave a $45.00M cash deficit after capital spending. Relative to revenue, the post-investment cash deficit represented 345.6%. The free-cash-flow deficit equaled 27.7% of total assets, placing the cash shortfall against the company’s resource base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for Nano-X Imaging Ltd.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $13.02M $11.28M $9.91M
Cost of Revenue $25.81M $21.89M $16.50M
Gross Profit $-12.79M $-10.61M $-6.59M
OPERATING EXPENSES
R&D Expense $19.24M $20.18M $26.05M
SG&A Expense $21.59M $22.46M $24.27M
Other Operating Expenses (derived) $24.62M $3.50M $5.68M
Operating Income $-78.23M $-56.75M $-62.59M
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $1.42M $2.87M $1.65M
Pretax Income $-76.81M $-53.87M $-61.12M
Income Tax $-1.79M $-358.00K $-339.00K
Net Income $-75.02M $-53.52M $-60.78M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-1.16 $-0.91 $-1.08
Diluted Shares 64.79K 58.67K 56.37K
EBITDA $-77.05M $-55.63M $-61.39M
Depreciation & Amortization $1.19M $1.12M $1.20M
Balance Sheet
ASSETS
Cash & Equivalents $49.15M $39.30M $56.38M
Short-term Investments - $18.40M $26.01M
Accounts Receivable $367.00K $112.00K $55.00K
Inventory $3.07M $1.49M $2.36M
Other Current Assets $845.00K $1.35M $1.09M
Current Assets $66.79M $78.68M $88.64M
PP&E (Net) $29.68M $45.36M $42.34M
Goodwill $316.00K - -
Intangible Assets $59.87M $70.00M $80.61M
Other Noncurrent Assets $1.63M $1.79M $2.16M
Noncurrent Assets $95.37M $131.32M $130.01M
Total Assets $162.17M $210.00M $218.65M
LIABILITIES
Accounts Payable $2.89M $2.21M $3.30M
Short-term Debt $3.14M $3.06M $3.49M
Other Current Liabilities $4.85M $3.85M $3.41M
Current Liabilities $16.89M $13.97M $15.52M
Other Noncurrent Liabilities $990.00K $695.00K $612.00K
Noncurrent Liabilities $5.55M $6.91M $7.61M
Total Liabilities $22.43M $20.88M $23.13M
EQUITY
Common Stock $198.00K $181.00K $165.00K
Additional Paid-in Capital $588.30M $562.69M $515.89M
Retained Earnings $-448.77M $-373.75M $-320.23M
Accumulated OCI - $-1.00K $-305.00K
Total Equity $139.73M $189.12M $195.51M
Total Liabilities & Equity $162.17M $210.00M $218.65M
SUPPLEMENTAL
Shares Outstanding 69.59M 63.76M 57.78M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-40.79M $-36.60M $-44.78M
Capital Expenditures $4.21M $2.77M $3.30M
Cash from Investing $29.37M $-20.05M $35.43M
Cash from Financing $21.37M $39.50M $27.25M
Free Cash Flow $-45.00M $-39.37M $-48.08M
Beginning Cash (CFS) $39.30M $56.38M $38.53M
Net Change in Cash $9.95M $-17.15M $17.91M
Effect of FX on Cash $-101.00K $72.00K $-60.00K
Calculated Ending Cash $49.15M $39.30M $56.38M
Cash per BS $49.15M $39.30M $56.38M
Cash scope difference (CFS − BS) - - -
Cash per CFS $49.15M $39.30M $56.38M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Nano-X Imaging Ltd.'s annual revenue?

Nano-X Imaging Ltd. reported $13.02M in revenue for fiscal year 2025 (ending December 2025). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is Nano-X Imaging Ltd. profitable?

No. Nano-X Imaging Ltd. reported $-75.02M in net income for fiscal year 2025. Profitability data is based on the company's most recent annual report filed with the SEC.

Does Nano-X Imaging Ltd. generate free cash flow?

No. Free cash flow was $-45.00M for fiscal year 2025. Operating cash flow was $-40.79M.

Related Companies

X-Ray Apparatus & Tubes & Related Irradiation Apparatus